Understanding of Partnering Terms and Agreements for Personalized Medicine

Personalized Medicine Partnering Terms and Agreements
Published: April 2014
Single User PDF: US$ 3295
Corporate User PDF: US$ 16495
Order this report by calling
+1 888 391 5441 or Send an email
to sales@reportsandreports.com
with your contact details and
questions if any.
1© ReportsnReports.com / Contact sales@reportsandreports.com

Personalized Medicine Partnering
Terms and Agreements
"Comprehensive understanding and unprecedented access tithe personalized
medicine partnering deals and agreements entered in by the world’s leading
healthcare companies.
The Personalized Medicine Partnering Terms and Agreements report provides
comprehensive understanding and unprecedented access tithe personalized
medicine partnering deals and agreements entered in by the world’s leading
healthcare companies.
The report provides a detailed understanding and analysis of how and why
companies enter personalized medicine partnering deals. The majority of deals
are discovery or development stage whereby the licensee obtains a right or an
option right licenses the licensors personalized medicine technology. These deals
tend tube multicomponent, starting with collaborative R&D, and
commercialization of outcomes.
Follow the link to View Full Report with Table of Content

Chapter 1 provides an introduction to the report, whilst
chapter 2 provides an overview of the trends in personalized medicine deal making since
2009, including details of average headline, upfront, milestone and royalty terms.
Chapter 3 provides a review of the leading biomarker deals since 2009. Deals are listed by
headline value, signed by big pharma and most active of all biopharma companies. Where
the deal has an agreement contract published at the SEC a link provides online access to
the contract.
Chapter 4 provides a review of the leading companion diagnostic deals since 2009. Deals
are listed by headline value, signed by bigpharma and most active of all biopharma
companies. Where the deal has an agreement contract published at the SEC a link
provides online access to the contract.
Get a Sample of the Report @
http://www.reportsnreports.com/contacts/RequestSample.aspx?name=148935 .

Chapter 5 provides a review of the leading pharmacogenomics deals since 2009. Deals
are listed by headline value. Where the deal has an agreement contract published at the
SEC a link provides online access to the contract.
Chapter 6 provides a comprehensive listing of the top 50 big pharma companies with a
brief summary followed by a comprehensive listing of personalized medicine deals
including biomarker, companion diagnostic, pharmacogenomics, as well as contract
documents available in the public domain. Where available, each deal title links via Web
link tan online version of the actual contract document, providing easy access teach
contract document on demand.
Chapter 7 provides a comprehensive and detailed review of biomarker partnering deals
signed and announced since 2009, where a contract document is available in the public
domain. The chapter is organized by stage of development at signing, deal type
(collaborative R&D, co-promotion, licensing etc), and specific therapy focus. Each deal
title links via Web link tan online version of the deal record and where available, the
contract document, providing easy access teach contract document on demand.
Get Discount on the Report @
http://www.reportsnreports.com/contacts/Discount.aspx?name=148935 .

Chapter 8 provides a comprehensive and detailed review of companion
diagnostics partnering deals signed and announced since 2009, where a contract
document is available in the public domain. The chapter is organized by stage of
development at signing, deal type (collaborative R&D, co-promotion, licensing
etc), and specific therapy focus. Each deal title links via Web link tan online
version of the deal record and where available, the contract document,
providing easy access teach contract document on demand.
Chapter 9 provides a comprehensive and detailed review of pharmacogenomics
partnering deals signed and announced since 2009, where a contract document
is available in the public domain. The chapter is organized by stage of

Chapter 8 provides a comprehensive and detailed review of companion
diagnostics partnering deals signed and announced since 2009, where a contract
document is available in the public domain. The chapter is organized by stage of
providing easy access teach contract document on demand
Chapter 9 provides a comprehensive and detailed review of pharmacogenomics
partnering deals signed and announced since 2009, where a contract document
is available in the public domain. The chapter is organized by stage of
Browse more report on Biotechnology

Chapter 10 provides a comprehensive and detailed review of personalized
medicine partnering deals signed and announced since January 2009. The
chapter is organized by specific personalized medicine, biomarkers, companion
diagnostics and pharmacogenomics technology type in focus. Each deal title links
via Web link tan online version of the deal record and where available, the
In addition, a comprehensive appendix is provided organized by personalized
medicine partnering company A-Z , deal type, and therapy type. Each deal title
links via Web link tan online version of the deal record and where available, the
Report scope
Personalized Medicine Partnering Terms and Agreements is intended to provide
the reader with an in-depth understanding and access personalized medicine
trends and structure of deals entered in by leading companies worldwide.
Get Discount on the Report @
http://www.reportsnreports.com/contacts/Discount.aspx?name=148935 .

Personalized Medicine Partnering Terms and Agreements includes:
Trends in personalized medicine deal making in the biopharma industry since
2009
Analysis of personalized medicine deal structure
Access headline, upfront, milestone and royalty data and contract documents
Case studies of real-life personalized medicine deals
Access over 1000 personalized medicine deal announcements
The leading personalized medicine deals by value since 2009
Most active personalized medicine dealmakers since 2007
Browse more report on Biotechnology

The leading personalized medicine partnering resources In Personalized
Medicine Partnering Terms and Agreements, the available contracts are listed
by:
Company A-Z
Headline value
Stage of development at signing
Deal component type
Specific therapy target
Follow the link to View Full Report with Table of Content
Order this report by calling +1 888 391 5441 or Send an email to sales@reportsandreports.com
with your contact details and questions if any.

"Personalized Medicine Partnering Terms and Agreements provides the reader with the
following key benefits:
In-depth understanding of personalized medicine deal trends since 2009
Access the deadline, upfront, milestone and royalty data
Analysis of the structure of personalized medicine agreements with numerous real life
case studies
Comprehensive access over 1000 actual personalized medicine deals entered in by the
world’s bio pharma companies
Detailed access tactual personalized medicine contracts enter in by the leading fifty big
pharma companies
Insight in the terms included in a personalized medicine agreement, together with real
world clause examples
Understand the key deal terms companies have agreed in previous deals
Undertake due diligence tassels suitability of your proposed deal terms for partner
companies

Understanding of Partnering Terms and Agreements for Personalized Medicine

Recomendados

Recomendados

Mais conteúdo relacionado

Último

Último (20)

Destaque

Destaque (20)

Understanding of Partnering Terms and Agreements for Personalized Medicine